Quantel Signs a Distribution Agreement With US-based National Biological

LES ULIS, France -

- National Biological to Market Quantel`s 308 Excimer System for Psoriasis and Vitiligo in the United States

Quantel SA (Euronext: QUA), a leading manufacturer of solid state lasers, announced today that it has entered into a Distribution Agreement with National Biological, a leading researcher and developer of light-based systems for medical and cosmetic treatments, for Quantel’s 308 Excimer System for monochromatic UVB treatment of psoriasis and vitiligo in the United States.

Monochromatic UVB Therapy

The 308 Excimer System was developed by Quantel Derma, GmbH based in Erlangen, Germany. Its monochromatic light is equivalent to an excimer laser, with comparable clinical results. The 308 Excimer System is portable, efficient and has no consumables.

National Biological’s Chief Executive Officer, Ken Oif commented, “The Quantel 308 targeted phototherapy System provides the best solution for the tens of thousands of patients who require localized treatment for psoriasis, vitiligo, and other skin diseases which are responsive to UV light. It is proven to be very effective and extremely easy to use. National Biological is very pleased to be able to provide Dermatologists with the best value of any targeted phototherapy system.”

Exclusivity in the United States

The 308 Excimer System will be exclusively marketed by National Biological in the United States. National Biological will provide the Marketing, Sales, Clinical and Service support.

Alain de Salaberry, Quantel’s Président Directeur Général said: “Its strong sales organization and its experience with UVB devices make National Biological an ideal partner for the marketing of Quantel’s 308 Excimer System.”

ABOUT THE QUANTEL Group

Founded in 1970, the QUANTEL Group has over the last 10 years established itself as one of the world’s leading specialists for scientific (research laboratories, universities), industrial (micromachining, metrics, military) and medical (ophthalmology, dermatology) laser technologies.

ABOUT Nation Biological Corporation, Inc.

National Biological was founded in 1967 by a pharmacist who understood clearly that UV phototherapy provided a safer and more effective treatment than drugs for severe or chronic psoriasis, eczema, vitiligo and other skin conditions. Over the nearly 40 years since then, National Biological has become widely recognized among doctors and patients alike as the world leader in our field, consistently providing innovation, manufacture, and distribution of phototherapy equipment.

Quantel is listed on NYSE Euronext (compartiment C) FR0000038242 - QUA

www.quantel-laser.com

Alain de SALABERRY Président Directeur Général T : +33-1-69-29-17-00 info@quantel.fr Stefan SCHULZE CEO Quantel Derma GmbH T : +49-9131-9408810 info@quantel-derma.com Mark Friedman President T : +1-216-831-0600 Info@PhototherapyExperts.com

Source: QUANTEL

Alain de SALABERRY, Président Directeur Général, T : +33-1-69-29-17-00, info at quantel.fr; Stefan SCHULZE, CEO Quantel Derma GmbH, T : +49-9131-9408810, info at quantel-derma.com; Mark Friedman, President, T : +1-216-831-0600, Info at PhototherapyExperts.com